PARP Inhibitors in Ovarian Cancer: A Review

Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPis) have transformed the ovarian cancer (OC) treatment landscape. This narrative review provides a comprehensive overview of data for the PARPis olaparib, niraparib, and rucaparib in patients with OC and discusses their role in disease management, w...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Malley, David M., Krivak, Thomas C., Kabil, Nashwa, Munley, Jiefen, Moore, Kathleen N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344972/
https://www.ncbi.nlm.nih.gov/pubmed/37268756
http://dx.doi.org/10.1007/s11523-023-00970-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344972/
https://www.ncbi.nlm.nih.gov/pubmed/37268756
http://dx.doi.org/10.1007/s11523-023-00970-w

Ejemplares similares